LightDeck Diagnostics

Boulder, United States Founded: 2009 • Age: 17 yrs Acquired By Heska
Point-of-care diagnostic devices for multiplex assays are developed.

About LightDeck Diagnostics

LightDeck Diagnostics is a Healthcare company based in Boulder (United States) founded in 2009 by Mike Lochhead, and was acquired by Heska in September 2022. Point-of-care diagnostic devices for multiplex assays are developed. LightDeck Diagnostics has raised $57.02 million across 16 funding rounds from investors including HHS, Heska and DARPA. Its chief executive, as recorded, is Nick Traggis. LightDeck Diagnostics offers products and services including COVID-19 Antigen Test, COVID-19 Antibody Test, Hormones Test, Host Response Test, and Cardiac Markers Test. Its focus areas include Diversified Diagnostics, Tests and Point Of Care. Its competitors include ProciseDx, LumiraDx and Abaxis; 2 of its 3 listed competitors have raised funding.

Company details

LightDeck Diagnostics was founded in 2009 in Boulder, United States, within the medical diagnostics sector. Point-of-care devices for multiplex assays are developed using the proprietary LightDeck platform, which integrates an advanced laser waveguide with novel materials and manufacturing techniques. In vitro diagnostic panels are provided through this system. The flagship MBio Array System employs disposable cartridges for automated and simultaneous fluorescence immunoassays.

  • Headquarters Boulder, United States
  • Founders Mike Lochhead
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website lightdeckdx.com
  • Social LinkedIn X
  • Acquired by Heska (Sep 2022)
Operational Areas
Key Metrics
  • Total Equity Funding
    $57.02M (USD)

    in 16 rounds

  • Investors
    HHS

    & 7 more

  • Acquired by
    Heska

    (Sep 2022)

Products & Services of LightDeck Diagnostics

LightDeck Diagnostics offers a comprehensive portfolio of products and services, including COVID-19 Antigen Test, COVID-19 Antibody Test, Hormones Test, Host Response Test, and Cardiac Markers Test.

COVID-19 Antigen Test
Diagnostic Test

Detects current COVID-19 infections quickly for timely intervention

COVID-19 Antibody Test
Diagnostic Test

Identifies antibodies indicating prior COVID-19 exposure

Hormones Test
Diagnostic Test

Assesses thyroid and reproductive health markers in patients

Host Response Test
Diagnostic Test

Detects biomarkers in blood for overall immune response evaluation

Cardiac Markers Test
Diagnostic Test

Quickly evaluates chest pain for potential cardiac issues

Water Testing
Environmental Test

Checks for common toxins to ensure water safety standards

Funding Insights of LightDeck Diagnostics

LightDeck Diagnostics has successfully raised a total of $57.02M across 16 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $57.02M
  • Total Rounds 16
  • First Round $2.59M

    (Aug 2009)

  • Investors Count 8

Latest 10 of 16 funding rounds of LightDeck Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2022Grant––
Mar 2022$6.12MSeries B––
–
Mar 2021$1.73MSeries B––
–
Feb 2021$9.99MSeries B––
–
Oct 2020$11MSeries B–Incubic, Boulder Ventures
–
Jul 2020$6.15MSeries B––
–
Mar 2020$1.59MSeries B–DARPA
–
Aug 2018$6MSeries B–Heska
–
May 2018$620,000Series B––
–
May 2018$1.11MSeries B––
–
Valuation history

8 investors in total: 8 institutional.

Investors in LightDeck Diagnostics

LightDeck Diagnostics has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Heska and DARPA.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Entrepreneur mentorship and selective investments are provided by Incubic.
incubic.comLos Altos Hills, United States
Venture capital is offered by Boulder Ventures for innovative companies.
boulderventures.comBoulder, United States
Late-seed stage startups are invested in by Entrada Ventures.
entradaventures.comSanta Barbara, United States
nifa.usda.gov
1958darpa.milUnited States
Provider of diagnostic solutions for pet care
1988heska.comFort Collins, United States
A government-backed foundation providing seed-stage investments to support small businesses.
1950nsf.govArlington, United States
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for LightDeck Diagnostics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of LightDeck Diagnostics

16 people are tracked at LightDeck Diagnostics (4 in leadership, 4 in board & advisors, 8 in team).

NameRoleGroup
Mike Lochhead
Co-FounderLeadership
Nick Traggis
CEOLeadership
Rebecca Wagner
Director, Clinical Operations at LightDeck DiagnosticsLeadership
Jennifer Losasso, MS PHR, SHRM-CP
Human Resources DirectorLeadership
Andy Drenick
DirectorBoard & advisors
Robert J. Silverman
Executive ChairmanBoard & advisors
Judy O’Brien
DirectorBoard & advisors
Milton Chang
DirectorBoard & advisors
Sean Link
Sr. Software Engineer, DevOpsTeam
Brad Metziner
Senior Software EngineerTeam
Nick Carlucci
Proccess Development EngineerTeam
Adam Clark
Software EngineerTeam
Carter Dettor
Process EngineerTeam
Blair Whitworth
Mechanical EngineerTeam
Jonathan Shewell
Manufacturing Engineering ManagerTeam
Thomas Caracena
Process EngineerTeam
Premium access

Complete people profiles for LightDeck Diagnostics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of LightDeck Diagnostics

4 dated milestones of LightDeck Diagnostics across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded LightDeck Diagnostics is founded.
  2. Funding First funding round of $2.6M.
  3. Funding Latest funding round, Grant,.
  4. Exit Acquired by Heska.

Competitors of LightDeck Diagnostics

LightDeck Diagnostics has 3 listed competitors in our database, 2 of them funded. They include ProciseDx, LumiraDx and Abaxis.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
procisedx.com2018San Diego, United States$8.96M
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
lumiradx.com2014Waltham, United States$703.91M
Cloud based diagnostics platform for point of care diagnosing
abaxis.com1989California, United States564
Diagnostics company offering a comprehensive line of on-site diagnostic instruments and rapid tests
Premium access

Detailed competitors of LightDeck Diagnostics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Diagnostics & Lab Tech

3 companies that operate in the same segment as LightDeck Diagnostics (Diagnostics & Lab Tech) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
At-home health tests for biomarkers, nutrition, and hormone analysis.
2014Austin, Texas, United StatesUSD 330 M336
Blood testing services are offered using finger-prick microsamples.
2017Austin, Texas, United StatesUSD 37.7 M
Manufactures clinical diagnostic test kits
1971Irvine, California, United StatesUSD 4.45 M54
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lightdeck Diagnostics

Frequently Asked Questions about LightDeck Diagnostics

LightDeck Diagnostics was founded in 2009.

LightDeck Diagnostics is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.

Nick Traggis is the CEO of LightDeck Diagnostics, as recorded in our data.

LightDeck Diagnostics is a funded company, having raised a total of $57.02M across 16 funding rounds to date. The company's 1st funding round was a Series B of $1.11M, raised on Aug 2009.

LightDeck Diagnostics was founded in 2009 in Boulder, United States, within the medical diagnostics sector. Point-of-care devices for multiplex assays are developed using the proprietary LightDeck platform, which integrates an advanced laser waveguide with novel materials and manufacturing techniques. In vitro diagnostic panels are provided through this system. The flagship MBio Array System employs disposable cartridges for automated and simultaneous fluorescence immunoassays.

LightDeck Diagnostics's top competitors include LumiraDx, Abaxis and ProciseDx.

LightDeck Diagnostics offers COVID-19 Antigen Test, COVID-19 Antibody Test, Hormones Test, Host Response Test, and 2 more products and services.

LightDeck Diagnostics has 8 investors. Key investors include HHS, Heska, DARPA, NIFA, and Incubic.

Yes. LightDeck Diagnostics was acquired by Heska in September 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available